Wednesday, November 18, 2026

Response to AI feedback on Lifewave X39

 Hi Dr. Peter,

Thank you for taking the time to look into this and for sharing what you found. I appreciate thoughtful questions and concerns— they’re exactly the kind that help people make informed decisions.​  I had almost identical issues raised a couple of weeks ago by a friend in South Africa.

LifeWave’s Compliance team recommends that when questions about the science or independent opinions come up, the best approach is simply to point people to the official company resources so they can review the information for themselves. AI summaries and third-party articles can sometimes present incomplete or differing viewpoints, so looking at the primary materials is the most reliable path.

Here are the key places​ ​the company encourages you to start:

  • Official Science & Research page for X39
    lifewave.com/lifewaveinc/home/science/x39
    This page lists LifeWave’s patents and the research the company references, including studies related to the X39 patch and copper peptide (GHK-Cu) levels.

  • Compliance Resource Center
    lifewave.com/lifewaveinc/home/compliance
    You’ll find the company’s advertising and product claim guidelines here, which show exactly how LifeWave positions the products (general wellness, non-transdermal phototherapy patches that support energy flow, strength, stamina, and overall well-being — with no drugs or stimulants).

X39 is a patented form of phototherapy. The patches are non-transdermal (nothing enters the body through the skin). LifeWave’s approved messaging focuses on supporting the body’s natural energy flow and overall health and well-being through gentle stimulation of the skin with low levels of light.

I encourage you to review the materials above at your own pace. If you’d like, I’m happy to meet up with you and walk through any of the official resources. No pressure either way — I want you to have clear, company-provided information​ as you requested.

Looking forward to hearing your thoughts after you’ve had a chance to look.

​G​od Bless,
Chuck